Original research

Benefit equity of social health insurance in China and its provinces (2014–2020): implications for universal health coverage

Abstract

Introduction China has increased fiscal input into social health insurance (SHI) schemes to achieve universal health coverage. Our study aimed to examine the equity of SHI benefits in the country and five representative provinces over the period of 2014–2020.

Methods We analysed nationally and subnationally representative data from four waves (2014, 2016, 2018 and 2020) of the China Family Panel Studies. Benefit relative to consumption was assessed using concentration indices and concentration curves. We compared benefit distribution against health need across consumption quintiles. We further decomposed the change in the concentration index from 2014 to 2020.

Results The national concentration index for SHI benefit was pro-rich but became substantially less so over time, falling from 0.262 in 2014 to 0.133 in 2020. Poorer quintiles suffered more ill health but received a smaller share of SHI benefits compared with the richer quintiles. All five provinces improved in benefit equity to varying degrees. Reduced disparity between employee and resident schemes, and use of hospitals as the usual source of care, accounted for 44.47% and 14.70%, respectively, of the national improvement in SHI benefit equity.

Conclusion The benefit equity of SHI in China has improved, likely influenced by the narrowing funding gap between resident and employee scheme benefits. However, benefits remained skewed towards the richer groups with lower health need, revealing the resilience of an ‘Inverse Benefit Law’. We suggest risk-equalisation of SHI funds and coordinated reform in health financing and service delivery towards a greater focus on primary care.

What is already known on this topic

  • In China, a few studies have evaluated the distribution of provincial-level public health subsidies, revealing a pro-rich tendency. However, there is limited research on national-level equity in benefits and no assessment of changes over time.

  • Certain factors like income, health, distance to healthcare, use of healthcare services and insurance affect living-standard-related inequity in social health insurance (SHI) benefit, but few studies have attempted to explain change of inequity over time, and few have allowed for disparity in health need.

What this study adds

  • To our knowledge, this is the first study from China to assess the changes in SHI benefit equity (at both national and subnational levels) and explore the factors behind the changes. We reveal a considerable enhancement in equity, especially after 2016.

  • The study also revealed an ‘Inverse Benefit Law’, where poorer people suffered from a greater share of ill health but received a smaller share of SHI benefits.

  • Further analysis suggested that increasing funding for the resident scheme drove the improvement in equity of SHI benefit, while use of hospitals as the usual source of care also contributed substantially.

How this study might affect research, practice or policy

  • Recent efforts to harmonise SHI schemes, particularly the rise in funding level for resident scheme enrollees, has contributed to improved equity of SHI benefit in China and its provinces.

  • Substantial gaps remain in orienting the SHI benefit towards those with greater health needs, highlighting the urgent necessity for risk-equalisation in the allocation of SHI funds.

  • Increasing government spending on only the resident SHI scheme in an increasingly hospital-centric service model seems unlikely to sustainably transform SHI benefit equity in the future. It is advisable to introduce risk-equalisation in the allocation of SHI funds and better coordinate health financing and service delivery reforms to shift the focus of the health system towards primary care.

Introduction

Universal health coverage (UHC) requires a well-functioning health financing system that ensures sufficient financial and service coverage for all.1 A central theme of UHC is equity. Under resource constraints, it requires that those with low ability to pay and high healthcare needs should be prioritised in allocation of public financial subsidies.2 3 Many countries rely on social health insurance (SHI) schemes to improve equity of financial and service coverage.4 However, 67% of studies from low and middle-income countries (LMICs) in the Asia-Pacific-reported public health subsidies to be pro-rich,5 highlighting the need to assess and monitor the equity of allocation of SHI benefit.

In 2009, China launched a major health system reform, aiming to establish a basic health system covering all residents. On top of the long-existing Urban Employee Basic Medical Insurance Scheme (UEBMI), funded through mandatory contributions from employers and employees, the population coverage was expanded of the New Cooperative Medical Scheme (NCMS, launched in 2002) and the Urban Resident Basic Medical Insurance (URBMI, launched in 2008) to enrol almost every citizen outside the formal economic sector by 2011.6 7 As the government has been promoting real-time settlement of healthcare costs, patients increasingly just need to pay the copayment. In addition, the Chinese government gradually increased the premium collected from enrollees and the government subsidy to increase the revenue and expenditure of NCMS and URBMI,6 8–11 which were merged into the Urban Rural Resident Basic Medical Insurance (URRBMI) scheme over the period 2014–2020. In 2021, government spending on all SHI schemes amounted to more than two-fifths of the total government health budget.12 Meanwhile, total expenditures of the SHI fund (including both government subsidies and premiums) reached 2.4 trillion yuan (366 billion US$) in 2021, accounting for 31% of annual total health expenditures.12 Although covering a similar range of outpatient and inpatient services, the employee scheme’s revenue, as well as actual reimbursement rate, remained substantially higher than that of the resident scheme. Per-enrollee expense of the employee scheme in 2021 was 4164 Chinese yuan (CNY) (or 653 US$), 4.52 times the per-enrollee expense of the resident scheme (922 CNY or 145 US$)13 (see online supplemental appendix table 1 for changes in the difference over time between resident and employee schemes and five typical provinces).

Despite the importance and significant changes of SHI financing in China, few studies have assessed the equity of benefits at national level. Pan et al used the Urban Resident Basic Medical Insurance Survey from 2007 to 2011 to evaluate benefit distribution,14 and the China Family Panel Studies (CFPS) in 2014 and 2016 was used to assess the equity of medical insurance.15 They found that higher income groups benefited more from basic medical insurance than lower income groups; the data predate health insurance integration (2016). Furthermore, all these studies merely compared benefits across groups, without using concentration indices16 to quantify the degree of socioeconomic-related inequity, which could have allowed for comparison over time.

As key SHI policies are formulated within China’s diverse provinces though following a unified national framework, significant differences exist across provinces in health insurance entitlements and health service provision.17 18 Therefore, it is important to evaluate benefit distribution at the subnational level as well. Several studies have used concentration indices to evaluate the distribution of public health subsidies at provincial level in different regions of China (two from eastern,19 20 three from western,21–23 one from northern,24 two from central25 26 and none from southern China), covering the period 2003 to 2013. Most studies found the overall distribution of benefits to favour the rich, though with varying degrees of pro-richness (0.107 to 0.445). Two studies, from western China,21 22 showed improvements in benefit distribution. None of the studies used a common dataset to compare across provinces, and no studies assessed the period after 2016. Some studies used decomposition techniques to assess influences on distribution of SHI benefits, identifying socioeconomic factors, distance from health facilities, use of health facilities, and types of medical insurance.25 27 Few attempted to explain change of benefit equity over time.

To address these gaps in the literature, we assessed the equity of SHI benefit distribution against both consumption and health need from 2014 to 2020 in China overall, and in five provinces from different regions of the country. We also explored the determinants of overall change over the same period.

Methods

Data source

We used data from the nationally representative CFPS,28 which uses a Probability Proportional to Size method to collect data biennially at individual, household and community levels on society, economy, demographics, education and health.29 30 The CFPS oversamples the population in five provinces, each from a geographical region of the country: Liaoning (Northern), Shanghai (Eastern), Henan (Central), Guangdong (Southern) and Gansu (Western), so the subsamples for these five provinces were representative at the provincial level.31 Our analysis used adult data from 2014, 2016, 2018 and 2020.

Study variables

Living standards

The study ranked individuals by their household consumption, which included spending on individual-level household equipment and supplies, communications, education, entertainment, healthcare and other consumption. To account for variations in household size and composition, we adjusted expenditures by the equivalent adult number (AE).

Display Formula

where A is the number of adults in the household, K is the number of children, α represents the ‘cost of children’ and θ reflects the degree of economies of scale.16 Based on international experience, α was set to 0.5, while θ was set to 0.75.32 The carry-forward method33 was used to impute missing data on household consumption.

SHI benefits

Individual benefit (reimbursement from SHI) was calculated from self-reported data, by subtracting the out-of-pocket expenditure on healthcare from total medical expenses in the previous 12 months, which was the sum of inpatient and ambulatory care expenditure during this period. Outliers in the medical reimbursement measurement (ie, the top 0.5% of all cases) were mitigated through right-tailed Winsorization.34

Health need

Health need19 35 was assessed by participants’ self-rated health status, with those who reported their health as ‘unhealthy’ considered in need of health services. We also used self-reported status of having been diagnosed with any chronic disease in the previous 6 months as a health need indicator in sensitivity analysis (see online supplemental appendix table 2 for details).

Explanatory variables

We drew on Andersen’s Behavioral Model of Health Services Use to explore potential contributors to equity of health insurance benefit. Modifying Andersen’s model, we assessed three groups of determinants: predisposing factors, enabling factors and health need factors.36 37 Predisposing factors were gender, age, residence, marital status, level of education and the type of healthcare providers commonly chosen. Enabling (or disabling) factors were household consumption, residence in western region (considering the lag in general socioeconomic development and more sparsely located health infrastructure in this region compared with other areas) and the type of SHI. Health need factors were self-assessed health and the presence of chronic disease(s).

Statistical analysis

Concentration curves and concentration index

Concentration curves display the share of health insurance benefit accounted for by cumulative proportions of individuals in the population ranked from poorest to richest. If everyone had exactly the same benefit regardless of their standard of living, the concentration curve would be a 45° straight line, also known as the line of equality. If the benefit is higher among the poor, the concentration curve will lie above the equality line. The further the curve is above the equality line, the higher the concentration of benefit among the poor. The multiple comparison approach was performed to test dominance at the 5% significance level.38

The concentration index (CI) can quantify the degree of household consumption-related inequity of health insurance benefit. The CI equals zero in the absence of household consumption-related inequity. If the CI takes a positive (negative) value, there is a pro-rich (pro-poor) inequity. The formula we used for calculating the CI is as follows:

Display Formula

where C is CI, y is SHI benefit, μ is the mean of y and r is the fractional rank of the household consumption distribution.16

Decomposition of change in the CI

We used Wagstaff’s method39 to decompose the inequity in each wave and the Oaxaca method40 to further decompose the change of the CI, examining differences in inequity across cross-sectional units.

We decomposed change in the CI using the following equation:

Display Formula

where t indicates time period and Δ denotes first differences. This approach enables change in SHI benefit inequity to be decomposed into two fundamental components: changes in consumption-related inequality in the determinants of SHI benefit (∆Cη) and changes in the elasticities of SHI benefit with respect to these determinants (∆ηC). For a detailed discussion of the methodology, see online supplemental appendix.

The statistical analysis was carried out using RStudio V.2023.03.1 and STATA V.17.0.1. Individual cross-sectional weights were used for weighting adjustments in order to make valid statistical inferences. All expenditures were adjusted for price level using the average Consumer Price Index for 2020, as reported in the Chinese National Statistical Yearbook 2022. Monetary values were converted to 2020 US$ using the midpoint exchange rate on 31 December 2020.

Patient and public involvement

The data analysed in this study were derived exclusively from the CFPS, conducted by the Institute of Social Science Survey of Peking University. Patients or the public were not involved in the design, implementation or reporting of this study.

Results

Descriptive statistics

Table 1 presents the characteristics of study participants over the four survey waves. Average SHI benefit per person increased from 806 CNY, about 124 US$, in 2014, to 934 CNY in 2016 and 1052 CNY in 2018, with a slight decrease in 2020 (906 CNY, 139 US$). Most participants (over 70%) were covered by the resident scheme, which meant either NCMS or URBMI until 2016, or URRBMI after 2016. Between 12% (in 2014) and 15% (in 2020) were covered by UEBMI. The rest were covered by the alternatives of insurance (government or supplementary) or were uninsured. More detailed analysis showed that the distribution of insurance types and other variables was generally stable across the waves nationally and in the five provinces (online supplemental appendix tables 3–6).

Table 1
|
Characteristics of the study participants (2014–2020) (%, col)

Of note, people from the lower consumption quintiles tended to be more likely to be beneficiaries of the URRBMI (online supplemental appendix table 7), which means narrowing gaps between the benefits of resident and employee schemes benefited relatively more those with a lower level of consumption.

Distribution of SHI benefit at the national level from 2014 to 2020

The value of SHI benefit varied by consumption quintile. The CI for SHI benefit improved from 0.262 (p<0.001) to 0.133 (p<0.001). This improvement was further confirmed by the results of the dominance test (table 2 and figure 1). Dominance tests showed that the concentration curves were consistently positioned below the line of equality, indicating that the equity of SHI benefit remained pro-rich during this period.

Table 2
|
Distribution of social health insurance benefit by per-capita household consumption quintiles in 2014–2020
Figure 1
Figure 1

Concentration curves for social health insurance benefit in China.

Allocation of SHI benefit according to health need

Figure 2 compares the distribution of SHI benefit by consumption quintile, with health need represented by self-assessed existence of ill health. Across the four waves, the richest quintile experienced around 15% (range 15.18%–15.78%) of the total prevalence of ill health, yet their share of SHI benefit was above 29% (range 29.54%–38.76%). Meanwhile, the poorest quintile experienced over 25% (range 25.07%–26.56%) of the total prevalence of ill health and their share of SHI benefit was small (range 8.52%–15.93%). Of note, while the distribution of ill health was essentially unchanged over the four waves, there was an evident shift of SHI benefit from the richest quintiles (down by 9.22 percentage points) to the poorest two quintiles (up by 7.41 percentage points) from 2014 to 2020. Such a shift of benefit to the poorer quintiles, however, was not obvious when using proportion of people who reported having a chronic disease to represent health need (online supplemental appendix figures 1 and 2).

Figure 2
Figure 2

Distribution of SHI benefit in relation to healthcare need (self-assessed health status), in (a) 2014, (b) 2016, (c) 2018, and (d) 2020. SHI, social health insurance.

Heterogeneity in benefit equity at sub-national levels

Subnational analysis showed both similarities and differences (table 3). In 2014, all five provinces were better than the national average for CI of SHI benefit (0.262), with CI values ranging from the lowest (Shanghai) at 0.116 to the highest (Henan) at 0.254. In 2016, the CI values in Shanghai and Guangdong were better than the national average (0.281). Additionally, by 2018, the CI of Henan had also experienced an improvement (CI=0.165), placing it below the national level (0.184). In 2020, Gansu was the only province with a CI value (0.172) above the national average (0.133), and the only province with pro-richness that passed the dominance test. The values of concentration indices for Shanghai, Henan and Guangdong were the closest to 0 (CI 0.063 to 0.013, and 0.077) among the five provinces.

Table 3
|
Concentration Indices for five provinces in 2014–2020

Comparing the changes across provinces, Shanghai and Guangdong, where the gap in per-enrollee expenditures between the employee and resident schemes was the narrowest (see online supplemental appendix table 1), was also generally more equitable in SHI benefit between 2014 and 2020. The CI of Shanghai steadily declined from 2014 to 2018, although dominance tests indicated that the change was not significant. For Guangdong, dominance tests indicated that the improvement of the SHI benefit distribution from 2016 to 2020 was significant. Notably, Henan showed significant improvement during this period, transitioning from a relatively high CI value of 0.254 in 2014 to the lowest CI value, of 0.013, among the five provinces in 2020. CI values of Liaoning and Gansu, where the gaps between per-enrollee expenditures were the biggest, exhibited fluctuations between 2014 and 2018, before reducing in 2020, though the changes did not pass the dominance test (table 3). Figure 3 plots the concentration curves of all provinces, by survey years. It shows that the overall trend was a gradual approach towards the line of equity.

Figure 3
Figure 3

Concentration curves for social health insurance benefit in five provinces in (a) 2014, (b) 2016, (c) 2018, and (d) 2020.

Decomposition of change in the inequity of SHI benefit

The CI of SHI benefit decreased from 0.262 in 2014 to 0.133 in 2020. Table 4 shows the decomposition results of change in benefit inequity. Consumption was not the main variable of interest here, since it was the ranking variable. The largest contributor to reduced inequity of SHI benefit was membership of the resident scheme as compared with the employee scheme (accounting for 44% of the total reduction). The change was not driven by change in the CI of insurance status, but rather by reduced benefit gaps between resident and employee schemes, as reflected in change in the elasticity of insurance status against benefit in comparison with employee scheme members. The second largest contributor to reduced inequity of SHI benefit was self-reported use of hospitals (as compared with clinics) as the usual source of care (15%). This was mainly driven by changes in the CI of relying on hospitals as usual source of care, as reflected in the term ∆Cη (which amounted to −0.012, much larger than the term ∆ηC at −0.007). This was generally consistent with the results of the annual CI decomposition (online supplemental appendix tables 8–11).

Table 4
|
Decomposition of change in the inequities of social health insurance benefit: Oaxaca method (2014–2020)

The top three contributors to increased inequity from 2014 to 2020 were age, higher education status and the status of being uninsured. The contribution of age (−14%) was mainly driven by older members being increasingly likely to receive SHI benefit (∆ηC=0.016). Second, the status of college degree or above also contributed substantially to increased inequity (−18%). This was largely driven by the more educated being increasingly likely to receive SHI benefit (∆ηC= 0.023). Being uninsured (as compared with employee scheme enrolment) was the third largest contributor to increased inequity in benefit (−11%). This was driven by people with lower income being increasingly likely to be uninsured (as compared with those enrolled in the employee scheme), reflecting both changes in the distribution of uninsured status and that lower benefits were likely to be received by the uninsured. For the decomposition results of change in benefit inequity by province, see online supplemental appendix tables 12–16.

Discussion

To our best knowledge, this is the first study from China on the equity of SHI benefit allocation relative to both household consumption and health need and also the first analysis of SHI benefit equity both at the national level and for typical provinces representing different geographical areas. We observed a notable improvement in SHI benefit equity during this period, especially after 2016. However, it is worth noting that the concentration of SHI benefit in China was consistently skewed towards the richer population from 2014 to 2020 and revealed clearly the phenomenon that richer groups suffered less illness but enjoyed more benefit, relative to poorer groups. Second, we revealed subnational similarity and disparities reflecting the regional socioeconomic diversity of China. The central province of Henan saw significant improvement in the equity of health insurance benefits compared with the other provinces, while Shanghai (Eastern) seemed to be the more equitable province throughout most waves. Meanwhile, Gansu (Western) and Liaoning (Northern) lagged behind. Finally, decomposition analysis showed that enhanced benefits for resident scheme enrollees and the change associated with reliance on hospitals as the usual source of care (including both shifting away from primary care facilities to hospitals as a usual source of care, and increasing benefit equity for hospital services) accounted for 44.47% and 14.70%, respectively, of the improvement of equity in SHI benefit.

Strengths and limitations

Our study had several limitations. First, our calculation of SHI benefit used self-reported total healthcare expenditure and out-of-pocket expenditure per year, which relied on a long recall period that may exacerbate recall bias. The conventional approach to benefit incidence analysis estimates benefits using unit costs calculated by dividing aggregate expenditure by the weighted sum of utilisation reported in the survey data, multiplied by the number of visits or admissions. However, because the less well-off tend to use lower cost services, even healthcare expenditures on a visit or hospitalisation at a similar facility can vary substantially,41 so the use of unit costs might mask the likely lower overall gaps in both expenditure and benefit allocated.35 Such systematic bias is less likely using our approach. Second, caution is needed in interpreting the results as we used consumption as measure of living standards. The expansion of SHI benefits may boost consumption by reducing the need for individuals to save for future healthcare needs. Resident scheme members, who were generally poorer, experienced greater benefit expansion relative to employee scheme members, so our analysis might underestimate benefits to poorer groups, as some of them would have moved up the consumption gradient. Third, missing data for explanatory variables and healthcare expenditure meant the exclusion of a portion of the original sample during data analysis. This exclusion may have introduced selection bias and impacted the generalisability of our findings to the entire population. Finally, the dataset used did not include detailed information on healthcare utilisation, such as the different types of healthcare providers and whether reimbursement was for outpatient or inpatient care.27 To address this limitation, we used usual source of care to assess the potential effects of provider choice on benefit concentration indices. According to data from the China Health Statistical Yearbook 2018,42 the actual proportion of care-seeking at hospitals was 45.84%, which is relatively close to the proportion of patients who self-reported use of hospitals as usual source of care.

Interpretation in relation to previous studies

First, our finding that the CI of SHI benefit reduced particularly after 2016, along with the essentially stable distribution of ill health, suggests that consumption-related distribution of SHI benefit became more equitable nationally and between and within its provinces in general. This finding is consistent with previous national and international studies regarding expansion of SHI or harmonising benefit policies between rural and urban populations. Within China, integrating URBMI and NCMS has been shown to facilitate access to health services and improve equity,43 particularly for the poor.44 Under Indonesia’s expansion of health insurance, those with lower income received a bigger share of public healthcare benefits as compared with the well off.45 In India, comprehensive healthcare-related strategies since 2008 have significantly alleviated the financial burden on the poor and advanced equity.46

Second, we have also provided novel evidence on key factors driving changes in SHI benefit equity. We have shown that the ratio of per-enrollee expenditures between employee and resident schemes tended to reduce (online supplemental appendix table 1). As the resident scheme beneficiaries tended to be poorer than employee scheme beneficiaries (online supplemental appendix table 7), the growth of resident scheme benefit reduced the relative gap between employee and resident schemes and contributed to the decline of overall consumption-related inequity of SHI benefits. This trend is further illuminated by the decomposition of the CI of SHI benefits, which underscores that the increase in benefits of the resident scheme was the main contributor to the improvement of SHI equity.

Another main contributor to improved equity was that the poor became more likely to use hospital services.43 44 In other words, the recent improvement in SHI benefit equity was driven by an increasingly hospital-centric model of care, which was confirmed by a noticeable increasing trend in the utilisation of hospitals as compared with primary care providers.22 Similar to China, several countries such as Vietnam47 and India48 have developed SHI schemes that prioritise hospital care. This is understandably given that hospital care tends to be expensive. However, while such policies are likely to contribute to enhanced benefit equity, they may increase demand for hospital services and associated out-of-pocket payment49 50 when primary or ambulatory care could have been more cost-effective. For example, in Vietnam, 73% of total health expenditure occurs in hospitals, current health services are heavily reliant on hospital-based care and out-of-pocket payments significantly exceed the global average.51 Our findings and relevant evidence from other LMICs warn that hospital-centric models of SHI benefits may not be efficient or sustainable.52

Third, we observed large subnational differences at any one-time regarding equity of SHI benefits. This finding is consistent with a previous study that revealed subnational disparity in incidence of catastrophic health expenditure and medical impoverishment.53 Among the five provinces we studied, the difference between employee and resident schemes in Shanghai had always been relatively small, corresponding to relatively equitable allocation of SHI benefits there. Meanwhile, gaps between schemes were continuously larger in Gansu (Western) and Liaoning (Northern), so the distributional equity of SHI benefits of these two provinces continuously lagged behind those of Guangdong (southern) and Shanghai (Eastern), corresponding to the relative lag of Gansu and Liaoning in terms of economic development. Noticeably, Henan (Central), with a large proportion of people outside the formal employment sector, achieved the greater improvement with a narrower benefit gap between schemes, despite its lag in economic development relative to Liaoning. Overall, subnational heterogeneity of benefit equity suggests the importance of paying attention to the western and northern provinces and, once again, supports the case for narrowing the benefit gap between schemes.

Morever, our study revealed important remaining inequities in the distribution of SHI benefits, which adds weight to previous findings that public health benefits remained pro-rich, highlighting that increased financial inputs to SHI alone are insufficient to ensure equitable distribution of healthcare benefit.14 54 On one hand, the fact that poorer members have greater perceived health problems but less SHI benefit requires attention. This situation has persisted despite China’s high health insurance coverage and rising premium levels. Drawing from the ‘Inverse Care Law’ proposed by Julian Tudor Hart in 1971,55 we may dub this phenomenon the ‘Inverse Benefit Law’.

While China has notably propelled the UHC Service Coverage Index to a 79-point score by 2019, the country’s incidence of catastrophic health expenditure is higher than the global average, with a concerning upward trend, contrasting with countries like Malaysia in Asia that have either maintained low or lowered their incidence of catastrophic health expenditure.56 Our results suggest that seeking to enhance benefit equity through greater government subsidy without changing the hospital-centric service delivery model is unlikely to be sustainable. Indeed, while increased subsidy made benefit allocation more equitable, poorer members would be exposed to greater out-of-pocket payments for direct medical costs to receive such benefit, in addition to indirect and non-medical costs, as well as an increased premium that led some to either remain uninsured or drop out from enrolment.57 Moreover, incentivising hospital use is not likely to mean good value for money or represent sustainable health financing.21 58

Implications for policymaking

We draw several policy implications from this study. First, it is necessary to further harmonise employee and resident schemes, as the gap between them remains substantial. Second, the central government needs to strengthen its support to local governments to increase the benefits for resident insurance relative to employee insurance in areas with greater resource constraints, which also see persistent higher inequity in SHI benefits, despite following the same national policy framework. For areas with a high proportion of the population in employee insurance, efforts should be made to investigate potential inefficient or even wasteful use of healthcare resources, in order to generate the fiscal space to expand benefits for the less well off. Third, China cannot rely predominantly on continuously increasing fund allocations to improve equity without adjusting the service delivery model, particularly given slower economic growth. While hospital expenditures need to be contained, concurrent development in service delivery to reduce reliance on the hospital-centric model of care is critical. This will require joint efforts by the National Health Security Administration and National Health Commission to leverage financing reform towards strengthening primary care. Fourth, there is a pressing need for risk-equalisation in the allocation of SHI funds, to address the different levels of health need between richer and poorer members.

Implications for future research

Future studies on benefit equity would be improved by linking claims data to household survey data. In addition, as the provinces, we studied exhibited different rates of change in equity, it will be important to study additional provinces and delve deeper into the underlying causes.

Conclusions

This is the first national and subnational study of recent trends in equity in SHI benefit in China. Our research indicates that while there has been improvement in the equity of SHI benefit, there remains considerable room for improvement. The persistent skewness towards those with higher living standards and lower health need reveals the resilience of the ‘inverse benefit law’ despite efforts to develop SHI. Moreover, it is crucial to address the substantial disparities in benefit equity among provinces. Decomposition analysis identified that increasing benefit for resident scheme beneficiaries and reliance on hospitals as usual source of care were the two most important drivers of improved equity in SHI benefit. Further harmonising employee and resident schemes, changing the hospital-centric service delivery model and providing targeted assistance from central government to provinces lagging behind are critical steps towards achieving equitable SHI benefit in China.